Towa Pharmaceutical Co., Ltd.
Research Towa Pharmaceutical Co., Ltd. (4553.T) on Bullrun: market cap JPY 180.17B, P/E 21.8, dividend yield 2.2%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4553.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 180.17B
- P/E21.8
- Dividend yield2.2%
- Financial periodFY2026
- RevenueJPY 273.71B
- Revenue growth5.4%
- Net incomeJPY 5.25B
- Free cash flowJPY 6.30B
- Gross margin36.2%
Valuation Snapshot
latest market cap is JPY 180.17B; P/E is 21.8; dividend yield is 2.2%.
Peer valuation comparison
Latest P/E is 21.79x versus a Healthcare sector median of 21.69x.
Latest dividend yield is 2.23% versus a Healthcare sector median of 2.41% (7.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2026 | JPY 273.71B | JPY 5.25B | JPY 6.30B | 36.2% | 106.66 | JPY 45.31B | JPY 226.74B | JPY 178.10B |
| FY2025 | JPY 259.59B | JPY 18.99B | -JPY 7.82B | 36.5% | 385.71 | JPY 45.47B | JPY 230.98B | JPY 171.62B |
| FY2024 | JPY 227.93B | JPY 16.17B | -JPY 31.11B | 35.7% | 328.59 | JPY 29.65B | JPY 203.31B | JPY 155.89B |
| FY2023 | JPY 208.86B | JPY 2.20B | -JPY 27.93B | 34.8% | 44.72 | JPY 24.26B | JPY 161.52B | JPY 136.89B |
| FY2022 | JPY 165.62B | JPY 15.91B | JPY 8.55B | 42.4% | 316.19 | JPY 32.83B | JPY 140.70B | JPY 132.17B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 180.17B | 21.8 | 2.2% | 80 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 80 JPY, yield 2.2%.
| Year | Dividends/share |
|---|---|
| FY2026 | 80 JPY |
| FY2025 | 80 JPY |
| FY2024 | 60 JPY |
| FY2023 | 60 JPY |
| FY2022 | 0.34 JPY |
About Towa Pharmaceutical Co., Ltd.
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Towa Pharmaceutical Co., Ltd.'s market cap?
Towa Pharmaceutical Co., Ltd.'s market capitalization is JPY 180.17B.
What is Towa Pharmaceutical Co., Ltd.'s P/E ratio?
Towa Pharmaceutical Co., Ltd.'s price-to-earnings (P/E) ratio is 21.8.
Does Towa Pharmaceutical Co., Ltd. pay a dividend?
Towa Pharmaceutical Co., Ltd. has a dividend yield of 2.2%.
What does Towa Pharmaceutical Co., Ltd. do?
Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs.